Thursday - April 30, 2026
American Action Forum Issues Commentary: Onshoring Pharmaceutical Manufacturing - Ambiguity Complicates Potential Success
April 29, 2026
WASHINGTON, April 29 -- The American Action Forum issued the following commentary on April 28, 2026, by health care policy analyst Jack Leimann:

* * *

Onshoring Pharmaceutical Manufacturing: Ambiguity Complicates Potential Success

Executive Summary

* A prominent objective of the Trump Administration is onshoring pharmaceutical manufacturing to the United States to secure supply lines and enable American pharmaceutical self-reliance; its most re . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products